Study: COVID-19 vaccine for children appears safe after inflammatory syndrome
In a study reported yesterday in , children and adolescents previously diagnosed with multisystem inflammatory syndrome (MIS-C) reported no serious complications after COVID-19 vaccination. Almost all participants received the Pfizer COVID-19 vaccine. The Centers for Disease Control and Prevention COVID-19 vaccination for patients with a history of MIS-C, a rare and potentially fatal immune reaction to SARS-CoV-2 infection. According to , over 9,000 U.S. patients have been diagnosed with MIS-C, which appears to be on the decline.
鈥淎 big part of that decline is that COVID vaccination has been protective against this rare condition in those who have received it,鈥 Audrey Dionne, M.D., a pediatric cardiologist at Boston Children鈥檚 Hospital who served as co-leader for the study, funded by the National Institutes of Health.